Kinnevik AB

DB:IV61 Stock Report

Market Cap: €1.9b

Kinnevik Valuation

Is IV61 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IV61 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IV61's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IV61's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IV61?

Key metric: As IV61 is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for IV61. This is calculated by dividing IV61's market cap by their current book value.
What is IV61's PB Ratio?
PB Ratio0.6x
BookSEK 37.40b
Market CapSEK 21.49b

Price to Book Ratio vs Peers

How does IV61's PB Ratio compare to its peers?

The above table shows the PB ratio for IV61 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average6.6x
CHG CHAPTERS Group
3.7x85.8%€538.0m
PZS Scherzer
0.9x96.5%€65.3m
HYQ Hypoport
3.8x30.4%€1.3b
T2G Tradegate Wertpapierhandelsbank
17.9xn/a€2.2b
IV61 Kinnevik
0.6x102.2%€21.5b

Price-To-Book vs Peers: IV61 is good value based on its Price-To-Book Ratio (0.6x) compared to the peer average (6.6x).

Price to Book Ratio vs Industry

How does IV61's PB Ratio compare vs other companies in the DE Diversified Financial Industry?

2 CompaniesPrice / BookEstimated GrowthMarket Cap
PBB Deutsche Pfandbriefbank
0.2x35.3%US$716.73m
CSQ creditshelf
0.07xn/aUS$29.47k
No more companies available in this PB range
IV61 0.6xIndustry Avg. 1.0xNo. of Companies3PB00.81.62.43.24+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: IV61 is good value based on its Price-To-Book Ratio (0.6x) compared to the European Diversified Financial industry average (1x).

Price to Book Ratio vs Fair Ratio

What is IV61's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IV61 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate IV61's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IV61 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€6.53
€8.59
+31.5%
12.0%€10.32€6.97n/a6
Nov ’25€6.48
€9.02
+39.2%
8.4%€10.51€8.23n/a6
Oct ’25€7.26
€9.25
+27.5%
10.6%€11.19€8.09n/a6
Sep ’25€7.12
€9.25
+30.0%
10.6%€11.19€8.09n/a6
Aug ’25€7.70
€9.25
+20.2%
10.6%€11.19€8.09n/a6
Jul ’25€7.69
€11.04
+43.6%
14.1%€13.57€9.16n/a6
Jun ’25€10.82
€11.95
+10.5%
14.0%€14.19€9.80n/a6
May ’25€9.88
€11.76
+19.1%
12.2%€14.22€9.83n/a6
Apr ’25€10.25
€12.41
+21.1%
13.0%€14.75€10.19n/a5
Mar ’25€9.70
€12.41
+27.9%
13.0%€14.75€10.19n/a5
Feb ’25€9.89
€12.39
+25.3%
14.8%€14.61€9.74n/a5
Jan ’25€9.67
€11.73
+21.4%
17.8%€14.62€9.48n/a5
Dec ’24€8.52
€11.73
+37.7%
17.8%€14.62€9.48n/a5
Nov ’24€7.98
€12.43
+55.9%
21.0%€15.52€9.23€6.485
Oct ’24€9.23
€14.43
+56.3%
14.7%€18.08€12.20€7.265
Sep ’24€10.83
€14.43
+33.3%
14.7%€18.08€12.20€7.125
Aug ’24€12.29
€14.85
+20.9%
14.7%€18.60€12.55€7.705
Jul ’24€12.44
€14.74
+18.5%
14.9%€18.59€12.54€7.695
Jun ’24€13.45
€15.56
+15.7%
15.1%€18.97€12.79€10.826
May ’24€14.46
€15.56
+7.6%
15.1%€18.97€12.79€9.886
Apr ’24€13.38
€15.27
+14.1%
14.2%€18.05€12.68€10.256
Mar ’24€14.08
€15.27
+8.5%
14.2%€18.05€12.68€9.706
Feb ’24€14.08
€15.49
+10.0%
16.0%€19.12€12.47€9.895
Jan ’24€13.11
€15.49
+18.2%
16.0%€19.12€12.47€9.675
Dec ’23€14.57
€16.05
+10.2%
17.8%€19.35€12.62€8.525
Nov ’23€12.55
€15.85
+26.3%
17.4%€19.05€12.70€7.985

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Yeahka

HK$4.3b

An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.

4YE

HK$1.21

7D

-5.5%

1Y

-23.4%

Exor

€20.1b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

EYX

€93.65

7D

-0.8%

1Y

7.7%

Merchants Bancorp

US$1.9b

Operates as the diversified bank holding company in the United States.

3KD

US$38.80

7D

7.8%

1Y

26.8%